Mounjaro V Wegovy: Buy Online UK From £79.99

  • Genuine Novo Nordisk Wegovy from £79.99 with GPhC-registered pharmacy supply (#9012878)
  • Expert comparison guidance between Wegovy's GLP-1 action and Mounjaro's dual GIP+GLP-1 mechanism
  • 3-minute online assessment with prescriber review - no face-to-face appointments needed
  • Next-day cold-chain delivery with 6-week room temperature storage advantage over Mounjaro
Start free consultation

Treatment from £144.99

Takes under 2 minutes · 100% online
Person enjoying the outdoors

Check if you're eligible

Height 175 cm
Weight 82 kg
Your BMI
26.8
Check with prescriber
Start free consultation
Free · BMI thresholds shown are illustrative. Final eligibility is confirmed by a UK prescriber during your free consultation.
100% UK-based pharmacy Free advice & support Rated Excellent 2,400+ reviews
Which route suits you

Two clinically backed paths to results

A weekly GLP-1 injection or a daily capsule — each fully overseen by our UK pharmacy team, with no obligation to continue.

Treatment
Avg. weight loss
05%10%15%20%25%
Availability
Injection
Weekly pen · GLP-1
Avg. weight loss
~20%up to
Availability Available now
Pill NEW
Daily tablet · Oral GLP-1
Avg. weight loss
~17%up to
Availability Explore now
Live Pricing

Our Range

Prices update live and may change. The live table below always takes precedence.
All treatment is subject to a prescriber consultation and clinical approval.

Why Choose EverydayMeds For Your Mounjaro V Wegovy Decision?

Mounjaro V Wegovy: Your Complete UK Online Buying Guide

When comparing Mounjaro v Wegovy for online purchase in the UK, understanding the fundamental differences helps inform your decision. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural fullness hormone, whilst Mounjaro contains tirzepatide, which targets both GIP and GLP-1 receptors for a dual mechanism approach. At EverydayMeds, we supply genuine Novo Nordisk Wegovy as a prescription-only medicine, ensuring you receive authentic treatment with full clinical oversight. Our GPhC-registered online pharmacy (#9012878) eliminates the need for multiple GP visits whilst maintaining the highest safety standards.

The decision between Mounjaro v Wegovy often comes down to individual response, medical history, and prescriber recommendation. Both medicines require dose escalation - Wegovy follows a structured 17-week escalation to 2.4mg maintenance, whilst Mounjaro typically escalates over 16 weeks to either 10mg or 15mg maintenance. Our clinical team reviews each assessment individually, considering your medical history, current medications, and treatment goals to recommend the most suitable option. This personalised approach ensures you're not simply choosing between treatments, but selecting the medicine most likely to support your weight management journey alongside a reduced-calorie diet and increased physical activity.

Wegovy Pricing & Value When Comparing Mounjaro V Wegovy Options

Understanding the cost implications of Mounjaro v Wegovy helps with long-term planning for your weight management journey. Wegovy pricing at EverydayMeds starts from £79.99 for the 0.25mg starter pen, progressing through £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), to £209.99 for the 2.4mg maintenance dose. Our bundle options provide convenience and supply security - the Intro Duo (0.25mg & 0.5mg) costs £169.99, whilst the Progress Trio (0.5mg, 1mg & 1.7mg) is priced at £369.99. New customers apply code FIRST40 at checkout, whilst returning customers use code DOSE25 for additional savings on these prices.

When evaluating Mounjaro v Wegovy costs, consider the total treatment duration and maintenance requirements. Wegovy's dose escalation spans 17 weeks before reaching maintenance, requiring ongoing 2.4mg weekly injections for sustained benefit. Our Ultimate Stability Trio provides three months of 2.4mg maintenance supply for £649.99, ensuring treatment continuity without repeated ordering. The investment in prescription-only medicine reflects not just the medication cost, but comprehensive clinical oversight, genuine pharmaceutical supply, and ongoing prescriber support throughout your treatment journey.

Clinical Evidence: Mounjaro V Wegovy Research Findings

Both medicines in the Mounjaro v Wegovy comparison have robust clinical evidence, though direct head-to-head trials remain limited. Wegovy's efficacy was demonstrated in the landmark STEP trials, where patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks in STEP 1 (Wilding et al., NEJM, 2021). The STEP 2 trial showed around clinically studied weight loss in patients with type 2 diabetes, whilst STEP 5 demonstrated sustained clinically studied weight loss at two years.

When considering Mounjaro v Wegovy clinical profiles, both medicines work through incretin pathways but with different receptor targets. Wegovy's GLP-1 mechanism has additional cardiovascular benefits demonstrated in the SELECT trial, showing a 20% reduction in major cardiovascular events. Individual response varies significantly, making prescriber guidance essential when choosing between these prescription-only medicines for weight management support.

How Wegovy Works In The Mounjaro V Wegovy Mechanism Comparison

Understanding how Wegovy functions helps clarify the Mounjaro v Wegovy mechanism differences that influence treatment choice. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics glucagon-like peptide-1, a hormone naturally released after eating to signal fullness to your brain. This mechanism reduces appetite by acting on hypothalamic appetite centres, promotes earlier satiety during meals, and may reduce food cravings throughout the day. Unlike Mounjaro's dual GIP and GLP-1 approach, Wegovy focuses specifically on GLP-1 pathways, providing targeted appetite regulation. The once-weekly FlexTouch pen delivery system maintains consistent therapeutic levels, supporting sustained appetite control when used alongside a reduced-calorie diet and increased physical activity.

Streamlined Ordering Process For Mounjaro V Wegovy Decisions

EverydayMeds simplifies the Mounjaro v Wegovy decision process through our comprehensive online service designed specifically for UK patients. Complete our 3-minute clinical assessment covering medical history, current medications, previous weight management attempts, and treatment preferences - this information helps our prescribers recommend between Wegovy and alternative options. Your assessment undergoes thorough review by our qualified prescribers within three working days (or 24 hours with express service), who may request additional information or suggest the most suitable treatment option. Once approved, your prescription-only medicine ships via next-day cold-chain delivery, maintaining the temperature-controlled storage essential for medication efficacy. Our clinical team remains available throughout your treatment for dose adjustment guidance, side effect management, and ongoing support.

Storage Advantages: Mounjaro V Wegovy Practical Considerations

Storage requirements often influence the Mounjaro v Wegovy decision, particularly for patients with active lifestyles or frequent travel commitments. Wegovy offers significant storage flexibility, maintaining stability for up to six weeks at room temperature (below 30°C) once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. This advantage makes Wegovy more suitable for business travel, holidays, or situations where refrigeration access is uncertain. The FlexTouch pen system is pre-filled and ready to use, requiring no mixing or preparation, whilst the dose escalation schedule provides clear progression milestones. Store unused pens in the refrigerator at 2-8°C, protect from light, and never freeze or shake the medication to maintain therapeutic effectiveness.

Mounjaro V Wegovy: Personalised Treatment Selection Online

The Mounjaro v Wegovy choice ultimately depends on individual factors that our online clinical assessment process carefully evaluates. Patient response to previous GLP-1 treatments, presence of type 2 diabetes, cardiovascular risk factors, and lifestyle considerations all influence treatment selection. Some patients may respond better to Wegovy's focused GLP-1 mechanism, whilst others might benefit from Mounjaro's dual receptor approach. Our prescribers consider contraindications, drug interactions, and patient preferences when recommending between these prescription-only medicines.

EverydayMeds' approach to the Mounjaro v Wegovy decision prioritises safety and efficacy over convenience, ensuring you receive the treatment most likely to support your weight management goals. Both medicines are available through our GPhC-registered pharmacy (#9012878), with identical clinical oversight and delivery standards. Your prescriber can adjust treatment plans, switch between options if needed, and provide ongoing support throughout your weight management journey alongside dietary and exercise modifications.

Complete Your Mounjaro V Wegovy Assessment Today

Ready to resolve your Mounjaro v Wegovy decision with expert clinical guidance? Start your 3-minute online assessment at EverydayMeds to receive personalised treatment recommendations from our qualified prescribers. New customers can apply code FIRST40 at checkout for additional savings, whilst returning customers benefit from code DOSE25 on their continued treatment. Our comprehensive service includes clinical assessment, prescriber review, genuine Novo Nordisk Wegovy supply, and next-day delivery to your door. Visit https://everydaymeds.co.uk/collections/wegovy to begin your weight management journey with confidence, knowing you're receiving prescription-only medicine through a fully regulated UK pharmacy. Both Wegovy and Mounjaro are available from EverydayMeds - your prescriber can help determine which treatment aligns best with your individual needs and circumstances.

Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026

NEW

GLP-1, now in adaily pill

Meet the daily GLP-1 tablet — needle-free, taken on your schedule, and prescribed by UK pharmacists. Designed for flexibility.

Join the free waitlist
Track your progress

Your journey,in your pocket

Track Now

Meet the newGLP-1 pill

  • Once-daily tablet · room-temp storage
  • No needles, no fridge
  • Up to ~15–17% in trials
How treatment works

How GLP-1 treatments help

Reduces appetite

Helps you feel fuller, sooner — so portions naturally shrink.

Curbs cravings

Quietens food noise so snacking and cravings ease off.

Slows digestion

Food stays in your stomach longer, steadying hunger between meals.

Steady blood sugar

Supports more stable glucose levels through the day.

Is GLP-1 treatment right for you?

GLP-1 medicines are powerful and prescription-only for good reason. They suit many people very well — and they aren’t appropriate for everyone. Here’s a clear, honest picture before you decide.

You may be suitable

Criteria met
BMI of 30 or higher
BMI of 27+ with weight-related conditions
Struggled to lose weight with diet alone
Ready to pair with lifestyle changes

Speak to us first

Potential risk
Pregnant, trying to conceive, or breastfeeding
History of certain thyroid cancers
Certain pancreatic or digestive conditions
Under the age of 18

Ready to start your journey?

Track your progress

Your journey, in your pocket

Track your journey

Log every dose and watch your progress build.

Download now Free to download — takes a minute to set up. App Store and Google Play

AI Meal Tracking. Built for GLP-1 Appetites.

Point your camera at any meal and in 4–6 seconds it logs the calories, macros, weight, and fullness it expects.

Never miss a dose

A daily nudge keeps you on track.

How it works

Achieve your goals in just a few simple steps.

Step 1

Start Free Consultation

Select safe UK treatments. Quick answers.

Step 2

Review By Our Clinical Team

Our expert team will use your consultation as the basis of our recommendation and communicate with you.

Step 3

Get it delivered fast

We’ll deliver direct to you, as quickly as tomorrow.

Trusted by thousands

Real people, real change

Hannah M.
Lost 2 st 4 lb in a year

“The cravings that used to run my evenings just quietened down. Having a pharmacist to message made it feel safe.”

David O.
Lost 3 st in a year

“Discreet, simple and genuinely supportive. The dose steps were explained clearly every time.”

Priya S.
Lost 1 st 9 lb in a year

“I finally feel like food isn’t the loudest thing in my head. The delivery was always discreet and on time.”

Frequently asked questions